Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.07.010 ◽

2016 ◽

Vol 38 (9) ◽

pp. 2058-2070.e1 ◽

Author(s):

Njira Lugogo ◽

Christian Domingo ◽

Pascal Chanez ◽

Richard Leigh ◽

Martyn J. Gilson ◽

...

Keyword(s):

Efficacy And Safety ◽

Eosinophilic Asthma ◽

Severe Eosinophilic Asthma ◽

Term Efficacy ◽

Open Label Phase

Download Full-text

Long‐term efficacy and safety results from an open‐label phase III study ( UNCOVER ‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.15292 ◽

2018 ◽

Vol 33 (3) ◽

pp. 568-576 ◽

Author(s):

Y. Umezawa ◽

H. Torisu‐Itakura ◽

Y. Morisaki ◽

H. ElMaraghy ◽

K. Nakajo ◽

...

Keyword(s):

Plaque Psoriasis ◽

Treatment Withdrawal ◽

Phase Iii ◽

Efficacy And Safety ◽

Term Efficacy ◽

Open Label Phase ◽

Phase Iii Study

Download Full-text

The Long-Term Efficacy and Safety of Mepolizumab in Children from 6 to 11 Years of Age with Severe Eosinophilic Asthma

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7192 ◽

2019 ◽

Author(s):

J. Steinfeld ◽

A. Gupta ◽

M. Ikeda ◽

B. Geng ◽

J. Azmi ◽

...

Keyword(s):

Efficacy And Safety ◽

Eosinophilic Asthma ◽

Severe Eosinophilic Asthma ◽

Download Full-text

Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J)

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.15287 ◽

2018 ◽

Vol 33 (2) ◽

pp. 325-332 ◽

Author(s):

Y. Okubo ◽

T. Mabuchi ◽

K. Iwatsuki ◽

H. Elmaraghy ◽

H. Torisu-Itakura ◽

...

Keyword(s):

Japanese Patients ◽

Pustular Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Term Efficacy ◽

Generalized Pustular Psoriasis ◽

Subgroup Analyses ◽

Open Label Phase

Download Full-text

Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up

British Journal of Dermatology ◽

10.1111/bjd.20595 ◽

2021 ◽

Author(s):

K.A. Papp ◽

M.G. Lebwohl ◽

L. Puig ◽

M. Ohtsuki ◽

S. Beissert ◽

...

Keyword(s):

Plaque Psoriasis ◽

Interim Analysis ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Term Efficacy ◽

Open Label Extension ◽

Extension Trial

Download Full-text

Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

Schizophrenia Research ◽

10.1016/j.schres.2021.11.030 ◽

2022 ◽

Vol 239 ◽

pp. 83-91

Author(s):

Yuriy Filts ◽

Robert E. Litman ◽

Javier Martínez ◽

Lourdes Anta ◽

Dieter Naber ◽

...

Keyword(s):

Extension Study ◽

Efficacy And Safety ◽

Term Efficacy ◽

Open Label Extension

Download Full-text

PS1221 LONG-TERM EFFICACY AND SAFETY OF INOTERSEN FOR HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: NEURO-TTR OPEN-LABEL EXTENSION 2-YEAR UPDATE

10.1097/01.hs9.0000563168.52071.ab ◽

2019 ◽

Vol 3 (S1) ◽

pp. 557 ◽

Author(s):

T. Brannagan ◽

M. Waddington Cruz ◽

A.K. Wang ◽

M.J. Polydefkis ◽

P.J. Dyck ◽

...

Keyword(s):

Efficacy And Safety ◽

Transthyretin Amyloidosis ◽

Term Efficacy ◽

Open Label Extension ◽

Hereditary Transthyretin Amyloidosis

Download Full-text

P150 LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2020.08.083 ◽

2020 ◽

Vol 125 (5) ◽

pp. S21

Author(s):

A. Banerji ◽

J. Hao ◽

M. Yu ◽

J. Bernstein ◽

D. Johnston ◽

...

Keyword(s):

Extension Study ◽

Efficacy And Safety ◽

Term Efficacy ◽

Open Label Extension

Download Full-text

Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial

Allergy Asthma & Clinical Immunology ◽

10.1186/s13223-020-0409-3 ◽

2020 ◽

Vol 16 (1) ◽

Author(s):

Donald S. Levy ◽

Henriette Farkas ◽

Marc A. Riedl ◽

Florence Ida Hsu ◽

Joel P. Brooks ◽

...

Keyword(s):

Subgroup Analysis ◽

Hereditary Angioedema ◽

Efficacy And Safety ◽

C1 Inhibitor ◽

Phase 3 ◽

Term Efficacy ◽

Open Label Extension

Download Full-text

Long-Term Efficacy and Safety of L-BLP25 Vaccine in a Multi-Centre Open-Label Study of Patients with Unresectable Stage III NSCLC

Annals of Oncology ◽

10.1016/s0923-7534(20)33763-7 ◽

2012 ◽

Vol 23 ◽

pp. ix395 ◽

Author(s):

C. Butts ◽

R.N. Murray ◽

C.J. Smith ◽

P.M. Ellis ◽

K. Jasas ◽

...

Keyword(s):

Stage Iii ◽

Efficacy And Safety ◽

Open Label Study ◽

Label Study ◽

Term Efficacy ◽

Unresectable Stage ◽

Stage Iii Nsclc

Download Full-text

Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study

Modern Rheumatology ◽

10.3109/14397595.2013.865822 ◽

2013 ◽

Vol 24 (5) ◽

pp. 725-733 ◽

Author(s):

Yoshiya Tanaka ◽

Kazuhiko Yamamoto ◽

Tsutomu Takeuchi ◽

Hisashi Yamanaka ◽

Naoki Ishiguro ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Certolizumab Pegol ◽

Efficacy And Safety ◽

Term Efficacy ◽

Open Label Extension

Download Full-text